+ All Categories
Home > Documents > Imaging in Valvular Heart Disease: State of the...

Imaging in Valvular Heart Disease: State of the...

Date post: 28-May-2018
Category:
Upload: ledang
View: 214 times
Download: 0 times
Share this document with a friend
43
10/8/2017 1 Where Contrast Administration Makes a Difference Contrast 2017 State of the Art Linda D. Gillam, MD, MPH, FASE Chair, Cardiovascular Medicine Medical Director, CV Service Line Morristown Medical Center/Atlantic Health System Morristown, NJ Professor of Medicine Thomas Jefferson University No disclosures
Transcript

10/8/2017

1

Where Contrast Administration Makes a

Difference

Contrast 2017

State of the Art

Linda D. Gillam, MD, MPH, FASE

Chair, Cardiovascular Medicine

Medical Director, CV Service Line

Morristown Medical Center/Atlantic Health System

Morristown, NJ

Professor of Medicine

Thomas Jefferson University

No disclosures

10/8/2017

2

Contemporary Ultrasound

Contrast AgentsStabilized gas microspheres sized to pass through the smallest capillaries

Burns. In: Rumack et al, eds. Diagnostic Ultrasound. Vol 1. 2nd ed. St. Louis: Mosby; 1998:57.

RBC: 6-8 m

Microsphere: 2-5 m

Currently available agents

10/8/2017

3

POWER

Interaction of Ultrasound

and Microbubbles

Linearresonance

Nonlinearresonance

Transientscattering

POWER POWER

Fundamental

enhancement

Bubble

disruption

Harmonic

enhancement

Burns. In Rumack et al, eds. Diagnostic Ultrasound. Vol. 1. 2nd ed.

St. Louis: Mosby; 1998:57.

Principles of Harmonic Imaging

2.5 MHz

2.5 MHz• Tissue and blood reflect

at the fundamental

frequency

• Microbubbles reflect at

both the fundamental and

the harmonic frequencies

2.5 MHz2.5 MHz + 5 MHz

Burns. In Rumack et al, eds. Diagnostic Ultrasound. Vol. 1. 2nd ed.

St. Louis: Mosby; 1998:57.

10/8/2017

4

Fundamental and

Harmonic Contrast Imaging

Schrope and Newhouse. Ultrasound Med Biol. 1993;19:567.

Shapiro et al. Am J Roentgenol. 1998; 171:1203-1206.

Contrast

Tissue

It’s all about signal to noise!

10/8/2017

5

Machine Settings

• For most applications

– Aim to maximize non-linear harmonic reflecting responses

(MI 0.1-0.4)

• Improves signal to noise vs tissue

• Equipment

– Optimized settings (presets)

• Contrast agent specific

• Transducer specific

• For perfusion applications

– Controlled bubble destruction

– Works best with equipment specifically equipped to do

perfusion imaging

Technical capability and Operational excellence

Diagnostic capacity

Impact on diagnostic and prognostic thinking

Impact on therapeutic strategy

Cost effectiveness

Outcomes

Guyatt GH, Tugwell PX, Feeny DH, Haynes RB, Drummond M. A framework for clinical evaluation of diagnostic technologies. CMAJ 1986; 134:587-594.

Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making 1991; 11:88-94

10/8/2017

6

LVO/EBD, Doppler enhancement

LVEF, Quantitation of gradients

Prognosis/dx related to LV function and gradients

Rx: Devices/ intervention for AS

Cost effectiveness

Outcomes

Guyatt GH, Tugwell PX, Feeny DH, Haynes RB, Drummond M. A framework for clinical evaluation of diagnostic technologies. CMAJ 1986; 134:587-594.

Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making 1991; 11:88-94

10/8/2017

7

10/8/2017

8

10/8/2017

9

Case Examples

Left Ventricular Opacification

62 yo female with aortic and mitral valve disease

Is the EF <60%

Accurate LVEF needed for clinical decision making

10/8/2017

10

10/8/2017

11

10/8/2017

12

LVEF 64%

Stress echo

10/8/2017

13

With thanks to Sharon Mulvagh

62 yo female with atrial fibrillation

(spontaneously converted) and

dyspnea

10/8/2017

14

10/8/2017

15

Dx: Apical HCM

Not CAD

Another myopathy

10/8/2017

16

With thanks to Sharon Mulvagh, MD

Mulvagh: J Am Soc Echocardiogr 21:1179, 2008

52 yo male with NYHA Class

III Heart Failure

10/8/2017

17

10/8/2017

18

76 yo female with syncope

10/8/2017

19

4.4mps

10/8/2017

20

32 yo male with atrial

fibrillation and family history of

SCD

10/8/2017

21

10/8/2017

22

Dx: ARVD

10/8/2017

23

Myocardial Contrast Perfusion

Thanks to Tom Porter, MD

Post PCI

Thanks to Tom Porter

10/8/2017

24

Safety Concerns

10/8/2017

25

Class Box Warning

Old contraindications

10/8/2017

26

Current for all agents

Lumason®

and pediatric

10/8/2017

27

CARPA

Complement Activation Related

Pseudo-Allergy

CARPA Signs and Symptoms• Angioedema

• Bronchospasm

• Cyanosis

• Hypotension

• Low back pain

• Pruritis

• Urticaria

• Tingling sensation

• Hypoxemia

• Sneezing

10/8/2017

28

Acute Hypersensitivity

ReactionsIgE mediated type I

• Reaction after

repeated exposure

• Reaction is stronger

upon repeated

exposure

• Reaction does not

cease without

treatment

CARPA

• No prior exposure

necessary

• Reaction is milder

or absent upon

repeated exposures

• Spontaneous

resolution

Szebeni J. Toxicology 2005:216:106-121

Note that prior “allergic”

reaction is contra-indication to

use of same/similar agent

10/8/2017

29

Event Rates for Commonly Performed

Cardiovascular Procedures

Procedure Event Rate Event

CoronaryAngiography

1:1000 Death

Exercise TreadmillTesting

1:2500 MI or Death

SPECT Exam orRadionuclideVentriculography

1:1000 to1:10,000

Fatal Malignancy

ContrastEchocardiography

1:500,000 Death

Pulmonary Hypertension

10/8/2017

30

Main ML, Hibberd MG, Ryan A, Lowe TJ, Miller P, Bhat G. Acute mortality in critically ill patients undergoing echocardiography with or without an ultrasound contrast agent. JACC Cardiovascular imaging 2014;7:40-8.

Using propensity matching , CE associated

with a 28% lower mortality at 48 h in

comparison with patients undergoing nTTE

10/8/2017

31

Interatrial Shunt

Parker JM et al. Am J Cardiol2013;112:1039-1045

10/8/2017

32

Kalra A et al. JACC Cardiovasc Imaging 2014;7:206-7.

Cost-effectiveness

10/8/2017

33

Thx to Michael Main

Technical capability and Operational excellence

Diagnostic capacity

Impact on diagnostic and prognostic thinking

Impact on therapeutic strategy

Cost effectiveness

Outcomes

Guyatt GH, Tugwell PX, Feeny DH, Haynes RB, Drummond M. A framework for clinical evaluation of diagnostic technologies. CMAJ 1986; 134:587-594.

Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making 1991; 11:88-94

10/8/2017

34

And yet contrast is

underutilized

Contrast Echocardiography as a

Percentage of Total

Echocardiography

0.00%

0.50%

1.00%

1.50%

2.00%

2.50%

3.00%

3.50%

4.00%

4.50%

5.00%

Arlington Medical Resources

FDA Black Box Warning

*through June 2015

Thx to Michael Main

10/8/2017

35

Obstacles

• “Internal” (Lab operations)• Time

• Orders

• Consent

• Personnel with IV skills / Scope of practice

• Access to agent

• “External”• Cost considerations

• Black box warning

Decision Order/

Consent

Personnel Agent Machine

Optimization

/ Protocols

STREAMLINE

10/8/2017

36

Decision Order/

Consent

Personnel Agent Machine

Optimization/

Protocols

Decision Order/

Consent

Personnel Agent Machine

Optimization/

Protocols

10/8/2017

37

– Reduce/eliminate time to obtain order

• Incorporate order for contrast into order for

echocardiogram

• Standing orders

– a written document containing rules, policies,

procedures, regulations, and orders for the conduct

of patient care in various stipulated clinical situations

• Develop policy for consent

Order/

ConsentDecision Personnel Agent Machine

Optimization/

Protocols

10/8/2017

38

– Have ready access to personnel trained to

insert IV and administer agent– Create staffing model that ensures that echo labs

have qualified non-sonographer personnel available

» RN

» ?Cardiology fellow

– Cross-train sonographers ( scope of

practice/personal preference)

• In hospital on floors

– In-service for nursing staff

Decision Order/Conse

nt

Personnel Agent Machine

Optimization

/ Protocols

10/8/2017

39

– Have ready access to agent/equipment

• Consider storing in high use sites (ICU’s)

Decision Order/Cons

ent

Personnel Agent Machine

Optimization/

Protocols

10/8/2017

40

• Optimize machine settings

– Presets

• Agent specific

• Transducer specific

• Frequency specific

– Focal zone

• Protocols

– Infusion rate

– Look at more than the LV blood pool

• RV

• Great vessels

• Doppler

• Resource person

10/8/2017

41

Cost Considerations

“There is inadequate reimbursement to

cover the cost of contrast “

Solutions:

For outpatient studies, there is

reimbursement

Document guideline driven indication

For inpatient studies, cost of agent can be

recaptured by reduction in other costs

Create/defend contrast budget

Chest pain - angina?

DLVEF (chemo)

LVEF for ICD or BiV

Stress echo

Pericardial disease

Valve disease

Aortic dissection

LV Thrombus

Atrial fibrillation

Hypotension

Dyspnea

Quality of Images

poor fair good

Indication for Study

With thanks to Jonathan Lindner

10/8/2017

42

Summary

• Contrast has been repeatedly shown to

improve the accuracy and

reproducibility of LV volume /EF

assessment

– Multiple off label uses

• Safety profile is excellent

• After “hit” triggered by black box

warning utilization is increasing

Summary

• Thoughtful approach to streamlining all

steps in utilization chain is essential to

optimal utilization and appropriate use

of health care resources

10/8/2017

43


Recommended